Acetylcholine Release from Rat Diaphragm: A Search for Release Regulatory Mechanisms

  • J. Häggblad
  • E. Heilbronn
Part of the Advances in Behavioral Biology book series (ABBI, volume 30)


During the last five years there have been a number of reports concerned with possible muscarinic mechanisms at the motor nerve terminals of the phrenic nerve. Both positive and negative muscarinic feedback autoregulation of acetylcholine (ACh) release has been suggested, as well as an absence of any regulatory muscarinic receptor. The designs of the previously performed experiments differ from each other and from ours mainly in the technique used for ACh analysis. There are also differences in the use of anticholinesterases. It is possible that these differences in approach may have led to the divergent results. We decided to reinvestigate the possible involvement of a presynaptic muscarinic autoreceptor in ACh release from motoneurons. For this purpose a chemiluminescence technique for the quantitation of ACh released from mammalian neuromuscular preparations was developed. Nerve stimulation was accomplished either by 50 mM KCl or by electrical stimulation of the phrenic nerve.


Phrenic Nerve Acetylcholine Release Motor Nerve Terminal Nicotinic Antagonist Chemiluminescence Technique 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abbs, E.T. and Joseph, P.N. (1981): Br. J. Pharmac. 73: 481–483.Google Scholar
  2. 2.
    Das, M., Ganguly, D.K. and Vedasiromoni, J.R. (1978): Br. J. Pharmac. 62: 195–198.Google Scholar
  3. 3.
    Gundersen, C.B. and Jenden, D.J. (1980): Br. J. Pharmac. 70: 8–10.Google Scholar
  4. 4.
    Hâggblad, J. and Heilbronn, E. (1983): Br. J. Pharmac. 80: 471–476.Google Scholar
  5. 5.
    Hgggblad, J., Eriksson, H. and Heilbronn, E. (1983): J. Neurochem. 40: 1581–1584.CrossRefGoogle Scholar
  6. 6.
    Illes, P. and Thesleff, S. (1978): Br. J. Pharmac. 64: 623–627.Google Scholar
  7. 7.
    Isragl, M., Lesbats, B., Manaranche, R., Meunier, F.M. and Frachon, P. (1980): J. Neurochem. 34: 923–932.CrossRefGoogle Scholar
  8. 8.
    Isragl, M. and Lesbats, B. (1981): Neurochem. Int. 3: 81–90.CrossRefGoogle Scholar
  9. 9.
    Masland, R.L. and Wigton, R.S. (1940): J. Neurophysiol. 3: 269–375.Google Scholar
  10. 10.
    Miledi, R., Molenaar, P.C. and Polak, R.L. (1978): Nature 272: 641–643.CrossRefGoogle Scholar
  11. 11.
    Nordström, O. and Bartfai, T. (1981): Brain Res. 213: 467–471.CrossRefGoogle Scholar
  12. 12.
    Narahashi, T. (1974): Physiol. Rev. 54: 813–889.CrossRefGoogle Scholar
  13. 13.
    Polak, R.L. and Molenaar, P.C. (1974): J. Neurochem. 23: 1295–1297.CrossRefGoogle Scholar
  14. 14.
    Ribeiro, J.A. and Walker, J. (1975): Br. J. Pharmac. 54: 213–218.Google Scholar
  15. 15.
    Westlind, A., Grynfarb, M., Hedlund, B., Bartfai, T. and Fuxe, K. (1981): 215: 131–141.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • J. Häggblad
    • 1
  • E. Heilbronn
    • 1
  1. 1.Unit of Neurochemistry and NeurotoxicologyUniversity of StockholmSundbybergSweden

Personalised recommendations